TWST
Twist Bioscience Corp
182.80$
-0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.6% | -4.1% | -9.2% | -3.7% | -0.9% | -2.1% | +8.1% | -0.3% | -0.6% | +6.0% | -0.6% | |
| – | -8.0% | -4.7% | -2.7% | -4.2% | -0.4% | -2.0% | +0.4% | -2.0% | -8.7% | +6.4% | -0.7% | |
| – | -7.1% | -8.6% | -1.7% | -5.4% | -2.2% | -5.0% | -4.3% | -9.1% | -18.8% | -17.4% | -4.3% | |
| – | -7.5% | -5.7% | -1.3% | -4.5% | -2.0% | -5.1% | -2.5% | -7.3% | -14.8% | -13.3% | -2.8% | |
| – | -17.0% | +1.5% | -13.8% | +9.1% | +12.6% | +27.0% | -0.2% | +15.0% | -12.7% | +28.1% | +2.5% | |
| – | -3.7% | -1.6% | -6.2% | -15.5% | -2.3% | -11.3% | +24.3% | +9.1% | +16.3% | +1.8% | +4.9% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -4.2% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.4% | -2.4% | -71.6% | -1.8% | -1.8% | -1.9% | -1.9% | -1.9% | -2.0% | -1.3% | -2.0% | |
| – | -6.7% | 0.0% | +3.0% | -3.6% | +7.8% | +1.9% | +6.4% | +2.1% | +7.7% | +21.5% | +2.5% | |
| – | -11.0% | +3.5% | +9.3% | -3.7% | -1.9% | +7.7% | +16.1% | +5.0% | -12.0% | +49.1% | +0.2% | |
| – | -0.6% | -1.3% | -0.5% | +1.7% | +1.5% | +1.3% | +1.9% | -10.8% | -11.4% | -14.7% | -17.4% | |
| – | -34.1% | -16.8% | -14.0% | -75.4% | +360.3% | +7.5% | +48.6% | -7.4% | +12.6% | +17.5% | +16.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.4% | -5.1% | -12.3% | -3.8% | -3.5% | -3.5% | +8.7% | -1.1% | -3.6% | -0.2% | -2.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +0.5% | +0.6% | -0.2% | +2.0% | +0.8% | +2.5% | -1.2% | +1.1% | +1.0% | +1.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.